Euglycemic diabetic ketoacidosis with canagliflozin: Not-so-sweet but avoidable complication of sodium-glucose cotransporter-2 inhibitor use

Lignende værker

• Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
  af: Kelmenson, Daniel A., et al.
  Udgivet: (2017)
• Euglycemic diabetic ketoacidosis associated with the use of a sodium–glucose cotransporter-2 inhibitor
  af: Zhang, Lydia, et al.
  Udgivet: (2018)
• Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
  af: Peters, Anne L., et al.
  Udgivet: (2015)
• Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor
  af: Jazi, Mazen, et al.
  Udgivet: (2016)
• Sodium–Glucose Cotransporter 2 Inhibitors and Euglycemic Diabetic Ketoacidosis: Metabolic Acidosis With a Twist
  af: Jaberi, Aala, et al.
  Udgivet: (2016)